nicorandil has been researched along with Angor Pectoris in 138 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (11.59) | 18.7374 |
| 1990's | 39 (28.26) | 18.2507 |
| 2000's | 51 (36.96) | 29.6817 |
| 2010's | 29 (21.01) | 24.3611 |
| 2020's | 3 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Benedini, F; Bertolini, G; Cereda, R; Donà, G; Gromo, G; Levi, S; Mizrahi, J; Sala, A | 1 |
| Li, N; Liu, J; Qiu, L; Shen, L; Shu, H; Zhou, N | 1 |
| Haubjerg, L; Lundby, L; Meinert, M; Nathan, T | 1 |
| Carey, M; Elshaikh, A; Goel, H; Goyal, D; Krinock, M; Nadar, SK | 1 |
| Fujii, K; Hasegawa, K; Higashino, Y; Ishibuchi, K; Ishii, R; Kakishita, M; Kusumoto, H; Nakabayashi, S; Otsuji, S; Shimatani, Y; Takiuchi, S; Tamaru, H; Taniguchi, Y; Yamamoto, W; Yasuda, S | 1 |
| Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H | 1 |
| Graham, MM; Pearson, GJ; Turgeon, RD | 1 |
| Chen, T; Fang, X; Huang, J; Xu, X; Zheng, J; Zhu, H | 1 |
| Jones, DA; Timmis, A; Wragg, A | 1 |
| Ikari, Y; Kiyooka, T; Kobayashi, Y | 1 |
| Hirohata, A; Hirose, E; Kobayashi, Y; Matsumoto, K; Ohara, M; Ohe, T; Sano, F; Takafuji, H; Takinami, H; Yamamoto, K; Yoshioka, R | 1 |
| Goto, T; Matsui, M; Miyata, S; Momomura, S; Nihei, T; Odaka, Y; Ogawa, H; Seki, A; Shimokawa, H; Sueda, S; Sumiyoshi, T; Takagi, Y; Takahashi, J; Tanabe, Y; Tsunoda, R; Yasuda, S | 1 |
| Eshraghi, A; Nezafati, MH; Nezafati, P; Sani, HD; Shahri, B; Vojdanparast, M | 1 |
| Chang, SS; Chen, SC; Lee, CC; Lee, MT; Lee, SH; Lin, HY | 1 |
| Garg, T; Goyal, AK; Rath, G; Singh, B | 1 |
| Kozlova, NV; Shameeva, ES; Sizova, ZM; Zakharova, VL | 1 |
| Chatzizisis, YS; Giannoglou, GD; Giannopoulos, AA | 1 |
| Bai, S; Bi, X; Fan, Y; Fu, X; Li, W; Wang, Y; Wei, L; Xiao, Y | 1 |
| Meena, CB; Meena, DS; Parvez, J | 1 |
| Arora, R; Jawad, E | 1 |
| Adachi, Y; Doi, M; Naruse, S; Obata, Y; Sano, H; Sato, S; Suzuki, K; Takada, K | 1 |
| Akagi, S; Dan, K; Fujimoto, Y; Hisamatsu, K; Kawai, Y; Kusano, KF; Matsubara, H; Miyaji, K; Munemasa, M; Ohe, T | 1 |
| Baldwin, PJ; Chan, SK; Harris, MD; Sterling, JC | 1 |
| Adamson, B; Allan, SJ; Fraser, SJ; Pinion, SB | 1 |
| Corbishley, C; Lam, W; Perry, M; Philippou, P; Watkin, N; Yap, T | 1 |
| Battler, A; Dvir, D | 1 |
| Fitter, S; Hamzah, I; Harbach, L; McDaid, J; Reichl, C; Savage, AP | 1 |
| Atienza, P; de Parades, V; Fourti, MA | 1 |
| Hanai, Y; Hishinuma, S; Mita, M; Shoji, M | 1 |
| Araki, S; Izumiya, Y; Kaikita, K; Kojima, S; Matsubara, J; Nagayoshi, Y; Ogawa, H; Sakamoto, K; Sugiyama, S; Tsujita, K; Usuku, H | 1 |
| Highet, AS; Mikeljevic, J | 1 |
| Köster, R; Meinertz, T | 1 |
| Horita, S; Kirita, T; Komatsu, Y; Matsusue, Y; Minamiguchi, M; Yamamoto, K | 1 |
| Keane, P; Kinney, M; Nambirajan, T; O'Kane, H; O'Rourke, D | 1 |
| Schmutz, JL; Trechot, P | 1 |
| Babu, H; Barakat, T; Colvin, HS; Hinson, FL; Moussa, O; Palmer, JG; Slaughter, T | 1 |
| Lyon, CC; Smith, VM | 1 |
| Evans, CD; Loney, MD; Mukkanna, KS; Shaffrali, FC; Shams, K | 1 |
| Galiñanes, M; Loubani, M | 1 |
| Adachi, H; Hoshizaki, H; Isobe, N; Naito, S; Nogami, A; Oshima, S; Sugawara, M; Taniguchi, K; Toyama, T | 1 |
| Chayama, K; Matsuura, H; Sakai, K; Teragawa, H; Yamagata, T | 2 |
| Iwase, T; Sakamoto, H; Tamaki, S; Tsubokawa, A; Ueda, K | 1 |
| Kato, T; Yoshimoto, N | 1 |
| Eeckhout, E | 1 |
| Kaikita, K; Kojima, S; Miyamoto, S; Ogawa, H; Sakamoto, T; Sugiyama, S; Yoshimura, M | 1 |
| Dubois, D; Fabiani, P; Lacour, JP; Mantoux, F; Ortonne, JP; Passeron, T | 1 |
| Simpson, D; Wellington, K | 1 |
| Fraser, A; Loudon, M; O'Kelly, T; Suttie, S; Watson, A | 1 |
| Edwards, RJ; Lambiase, PD; Marber, MS; Redwood, SR | 1 |
| Ahn, YK; Cho, JG; Hong, SN; Hong, YJ; Jeong, MH; Kang, DK; Kang, JC; Kim, JH; Kim, KH; Kim, W; Lee, SH; Lee, YS; Lim, SY; Park, HW; Park, JC; Yun, KH | 1 |
| Fujii, S; Kitabatake, A; Oyama, N; Sakai, H; Urasawa, K | 1 |
| Arasaradnam, R; Bagley, J; Brown, S; Davies, B; Hunt, LM; Katory, M; Kelty, C; Shorthouse, AJ; Skinner, P; Slater, R | 1 |
| Hanafusa, T; Hoshiga, M; Ishihara, T; Nakaboh, A; Nakajima, D; Nakakoji, T; Nariyama, J; Negoro, N | 1 |
| Barbato, JC | 1 |
| Abe, Y; Date, T; Inada, K; Matsuo, S; Miyanaga, S; Mochizuki, S; Sugimoto, K; Taniguchi, I; Yamane, T | 1 |
| Hirano, K; Iizuka, T; Kawana, H; Kawashima, T; Nakamura, K; Noike, H; Ohsawa, H; Sakurai, T; Satoh, S; Shimizu, K; Sugiyama, Y; Takahashi, M | 1 |
| Berger, W; Dargie, H; Ford, I; Fox, K; Henderson, NJ; Hillis, S; McMahon, AD; McMurray, J; Stewart, S; Walker, A | 1 |
| Aoyama, T; Ichimiya, S; Ishii, H; Kanashiro, M; Kasuga, H; Maruyama, S; Matsubara, T; Matsuo, S; Mitsuhashi, H; Murohara, T; Naruse, K; Takahashi, H; Toriyama, T; Yamada, S | 1 |
| Lyon, CC; Smith, AJ; Tamuno, P; Walker, SL; Williams, C | 1 |
| Amano, T; Ichimiya, S; Ishii, H; Kanashiro, M; Matsubara, T; Mitsuhashi, H; Murakami, R; Murohara, T; Naruse, K; Ogawa, Y; Sakai, S; Uetani, T | 1 |
| Chen, JZ; Guo, JX; He, Q; Jia, SQ; Li, TD; Li, ZQ; Shan, YD; Wei, JP; Wu, ZG; Yang, XC; You, K; Zhu, WL | 1 |
| Bhagwandas, K; Kamath, S; Kembrey, K | 1 |
| Kaikita, K; Ogawa, H | 1 |
| Akbar, F; Bhowmick, A; Maw, A | 1 |
| Al-Kubati, W; Atuf, M; Baker, RP; Phillips, RK | 1 |
| Chaitman, BR; Sano, J | 1 |
| Inou, T | 1 |
| Akima, M; Aono, J; Sakai, K | 1 |
| Hisatome, I; Kato, M; Kinugawa, T; Kitamura, H; Matsumoto, T; Miyakoda, H; Noguchi, N; Ogino, K; Omodani, H; Osaki, S | 1 |
| Kaski, JC | 1 |
| Fox, K; Knight, C; Purcell, H | 1 |
| Inoue, M; Morikawa, M; Satake, N; Shibata, S; Zhou, Q | 1 |
| Bueno, O; Zavecz, JH | 1 |
| Ribeiro, C | 1 |
| Hongo, M; Nakatsuka, T; Sekiguchi, M; Takenaka, H; Uchikawa, S; Watanabe, N | 1 |
| Shetty, K | 1 |
| Ambrosio, G; Chiariello, M; Duilio, C | 1 |
| Hosoi, H; Hou, M; Igarashi, M; Iida, M; Ishiguro, S; Koyama, N; Morishita, T; Nakano, H; Yabe, Y; Yamazaki, J | 1 |
| Fukata, Y; Fukushima, H; Harada, K; Kaneta, S; Miwa, A; Ogawa, N | 1 |
| Richardson, PJ; Why, HJ | 1 |
| Blin, P; Guermonprez, JL; Peterlongo, F | 1 |
| Hughes, LO; Lahiri, A; Raftery, EB; Rose, EL | 2 |
| Roland, E | 1 |
| Bokor, D; Carotenuto, A; de Divitiis, M; de Divitiis, O; Di Somma, S; Liguori, V; Petitto, M | 1 |
| Hosoi, H; Iida, M; Komatsu, H; Koyama, N; Morishita, T; Nakano, H; Ohsawa, H; Uchi, T; Yabe, Y; Yamazaki, J | 1 |
| Ejima, J; Fujino, T; Kaji, Y; Kanaya, S; Kaneda, K; Maruyama, T; Moriyama, H; Niho, Y; Ohmura, I; Tsuda, Y | 1 |
| Fujita, H; Iwahashi, M; Kim, S; Maeda, K; Namura, H; Yamabe, H; Yano, T; Yokoyama, M | 1 |
| Aonuma, K; Hiroe, M; Igawa, M; Inada, M; Korenaga, M; Marumo, F; Ogawara, S; Okamoto, Y; Umezawa, S | 1 |
| Bona, M; Marsico, F; Micheletti, T; Specchia, G | 1 |
| Chang, MS; Chen, JW; Hsu, NW; Lee, WL; Lin, SJ; Ting, CT; Wang, SP | 1 |
| Carr, CS; Yellon, DM | 1 |
| Aisaka, K; Hirata, Y; Mabuchi, Y; Miyai, H | 1 |
| Agbo-Godeau, S; Joly, P; Lauret, P; Szpirglas, H; Szpirglas, R | 1 |
| Maisch, B | 1 |
| Humphrey, SJ | 1 |
| Brieger, DB; Freedman, SB; Hawkins, R; Rajaratnam, R | 1 |
| Bickel, C; Meyer, J; Rörig, J; Rupprecht, HJ; Tyrtania, A | 1 |
| Dohi, K; Fujimoto, S; Hashimoto, T; Inoue, F; Kawamoto, A; Uemura, S | 1 |
| Arai, M; Fujiwara, H; Hayakawa, K; Kawasaki, M; Matsubara, T; Matsuno, Y; Matsuo, H; Minatoguchi, S; Nishigaki, K; Noda, T; Segawa, T; Takemura, G; Uno, Y; Watanabe, S | 1 |
| Goa, KL; Markham, A; Plosker, GL | 1 |
| Bonnetblanc, JM; Boulinguez, S | 1 |
| Azul, AM; Crighton, A; Felix, D; Field, A; Porter, SR; Scully, C | 1 |
| Easaw, J; Falase, B; Youhana, A | 1 |
| Kamiyama, T; Kato, T; Maruyama, Y; Tanaka, S; Yoshimoto, N | 1 |
| Hashimura, K; Kato, Y; Kijima, Y; Matsu-ura, Y; Mori, I; Ueda, T; Yasuda, T | 1 |
| Hata, N; Kishida, H; Kunimi, T; Takano, M; Takano, T | 1 |
| Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Louis, AA; Manousos, IR | 1 |
| Buckley, MM; Fitton, A; Frampton, J | 1 |
| Bucx, JJ; Henneman, JA; Hugenholtz, PG; Kelder, JC; Kerker, JP; Meeter, K; Tijssen, JG | 1 |
| Diderholm, E; Frithz, G; Gudbrandsson, T; Hedbäck, B; Höglund, C; Moelstad, P; Perk, J; Sverrisson, JT; Ulvenstam, G | 1 |
| Wagner, G | 1 |
| Cadeddu, M; Cherchi, A; Lai, C; Lai, G; Onnis, E; Orani, E; Solinas, R | 1 |
| Kinoshita, M; Sakai, K | 1 |
| Kambara, H; Kawai, C; Nakamura, Y; Tamaki, S | 1 |
| Asanoi, H; Hosoda, S; Hosono, K; Ishida, K; Kato, K; Kurita, A; Kuroiwa, A; Seki, K; Shiina, A; Wakabayashi, C | 1 |
| Sakai, K | 1 |
| Ali, MS; Goldhammer, E; Silke, B; Taylor, SH; Verma, SP | 1 |
| Camm, AJ; Maltz, MB | 1 |
| Camm, AJ; Coltart, J; Griffith, M; Maltz, MB; Meany, TB; Richardson, P; Signy, M | 1 |
| Hashimoto, K; Inoue, T; Kinoshita, M; Mitsunami, K; Ohbayashi, Y; Taguchi, H | 1 |
| Aihara, T; Bando, M; Hamai, K; Hiasa, Y; Kataoka, Y; Nakai, Y; Wada, T | 1 |
| Bito, K; Itoh, M; Kawakita, S; Kinoshita, M; Mashiro, I; Mitsunami, K; Motomura, M; Nishikawa, S; Sawamura, M; Yamaguchi, S | 1 |
| Araki, H; Hayata, N; Nakamura, M | 1 |
| Hader, S; Leitold, M | 1 |
| Araki, H; Hayata, N; Matsuguchi, T; Nakamura, M | 1 |
| Nakamura, Y; Sakai, K; Sugimoto, T; Yamazaki, T | 1 |
31 review(s) available for nicorandil and Angor Pectoris
| Article | Year |
|---|---|
Cardioprotective and Antianginal Efficacy of Nicorandil: A Comprehensive Review.
Topics: Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vasospasm; Humans; Nicorandil; Nitrates; Vasodilator Agents | 2023 |
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2019 |
Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiovascular Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Ischemia; Nicorandil; Nitrates; Quality of Life; Ranolazine; Vasodilator Agents | 2018 |
Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
Topics: Aged; Angina Pectoris; Biomarkers; Elective Surgical Procedures; Female; Humans; Incidence; KATP Channels; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Postoperative Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents | 2019 |
Novel drugs for treating angina.
Topics: Acetanilides; Angina Pectoris; Benzazepines; Enzyme Inhibitors; Heart Rate; Humans; Ivabradine; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2013 |
Pharmacological approaches of refractory angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nicorandil; Nitrates; Ranolazine | 2016 |
Hypertrophic obstructive cardiomyopathy with multiple coronary arteries to right ventricular microfistulas: a case report and review of the literature.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Vessels; Female; Heart Ventricles; Humans; Metoprolol; Nicorandil; Syncope; Treatment Outcome; Vascular Fistula | 2017 |
Chronic stable angina pectoris.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetanilides; Angina Pectoris; Antihypertensive Agents; Benzazepines; Bosentan; Chronic Disease; Counterpulsation; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Murmurs; Humans; Ivabradine; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nicorandil; Oxygen Consumption; Perhexiline; Piperazines; Protein Kinase Inhibitors; Ranolazine; Sulfonamides; Trimetazidine; Vasodilator Agents | 2008 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine | 2010 |
[Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Controlled Clinical Trials as Topic; Endpoint Determination; Heart Rate; Humans; Nicorandil; Nitrates; Odds Ratio; Prospective Studies | 2010 |
[New agents for the therapy of angina pectoris].
Topics: Acetanilides; Angina Pectoris; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Drug Approval; Enzyme Inhibitors; Humans; Ivabradine; Nicorandil; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Vasodilator Agents | 2011 |
Nicorandil-induced oral ulceration: report of 3 cases and review of the Japanese literature.
Topics: Aged, 80 and over; Angina Pectoris; Anti-Arrhythmia Agents; Follow-Up Studies; Humans; Male; Nicorandil; Oral Ulcer; Tongue Diseases | 2011 |
Ischaemic preconditioning and outcomes after angioplasty: effects of drug therapy.
Topics: Adenosine; Angina Pectoris; Angioplasty, Balloon, Coronary; Bradykinin; Death, Sudden, Cardiac; Humans; Ischemic Preconditioning, Myocardial; Models, Biological; Myocardial Infarction; Nicorandil; Nitroglycerin; Potassium Channels; Randomized Controlled Trials as Topic; Receptors, Purinergic P1 | 2003 |
Nicorandil for angina--an update.
Topics: Angina Pectoris; Humans; Myocardial Infarction; Nicorandil; Treatment Outcome; Vasodilator Agents | 2003 |
Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
Topics: Adult; Aged; Angina Pectoris; Animals; Area Under Curve; Clinical Trials as Topic; Humans; Middle Aged; Nicorandil; Vasodilator Agents | 2004 |
[Coronary thrombotic angina].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Coronary Angiography; Coronary Artery Bypass; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Fibrinolytic Agents; Humans; Intra-Aortic Balloon Pumping; Nicorandil; Nitro Compounds; Vasodilator Agents | 2007 |
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Chronic Disease; Enzyme Inhibitors; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Nitro Compounds; Piperazines; Ranolazine; rho-Associated Kinases; Sinoatrial Node; Trimetazidine; Vasodilator Agents | 2007 |
Management of vasospastic angina--role of nicorandil.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Coronary Vasospasm; Humans; Niacinamide; Nicorandil | 1995 |
Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
Topics: Angina Pectoris; Animals; Anti-Arrhythmia Agents; Hemodynamics; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Potassium Channels | 1995 |
Pharmacologic therapy of angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents | 1995 |
Prescribing for angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Nitrates; Vasodilator Agents | 1994 |
[Anti-angina activity of potassium-channel activators].
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Humans; Niacinamide; Nicorandil; Potassium Channels | 1993 |
A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
Topics: Angina Pectoris; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Exercise Test; Humans; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1993 |
Nicorandil for angina.
Topics: Angina Pectoris; Humans; Niacinamide; Nicorandil; Vasodilator Agents | 1995 |
Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
Topics: Angina Pectoris; Animals; Clinical Trials as Topic; Female; Half-Life; Hemodynamics; Humans; Intestinal Absorption; Male; Myocardial Ischemia; Nicorandil; Potassium Channels; Tissue Distribution; Vasodilator Agents | 2000 |
[Aphthae or painful ulcers induced by nicorandil].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Dose-Response Relationship, Drug; Female; France; Humans; Male; Middle Aged; Nicorandil; Oral Ulcer; Stomatitis, Aphthous; Vasodilator Agents | 2000 |
The role of nicorandil in the treatment of myocardial ischaemia.
Topics: Angina Pectoris; Animals; Coronary Artery Bypass; Coronary Vessels; Hemodynamics; Humans; Myocardial Ischemia; Nicorandil; Potassium Channels; Protective Agents; Vasodilator Agents | 2001 |
Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. As
Topics: Acetanilides; Angina Pectoris; Arrhythmias, Cardiac; Cardiology; Clinical Trials as Topic; Comorbidity; Coronary Disease; Defibrillators, Implantable; Depressive Disorder; Electric Countershock; Female; Heart Failure; Humans; Male; Nicorandil; Piperazines; Ranolazine; Sensitivity and Specificity | 2002 |
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Topics: Angina Pectoris; Animals; Biological Availability; Drug Interactions; Drug Tolerance; Hemodynamics; Humans; Niacinamide; Nicorandil; Nitrates; Potassium Channels; Vasodilator Agents | 1992 |
Pharmacology and therapeutic effects of nicorandil.
Topics: Angina Pectoris; Animals; Coronary Vessels; Drug Interactions; Hemodynamics; Humans; Niacinamide; Nicorandil; Vasodilator Agents | 1990 |
Nicorandil: animal pharmacology.
Topics: Angina Pectoris; Animals; Coronary Vasospasm; Dogs; Drug Tolerance; Niacinamide; Nicorandil; Vasodilator Agents | 1989 |
43 trial(s) available for nicorandil and Angor Pectoris
| Article | Year |
|---|---|
Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angina, Stable; Antihypertensive Agents; Coronary Circulation; Coronary Vessels; Female; Humans; Male; Microcirculation; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Stents; Treatment Outcome; Vascular Resistance | 2014 |
Nicorandil Versus Nitroglycerin for Symptomatic Relief of Angina in Patients With Slow Coronary Flow Phenomenon: A Randomized Clinical Trial.
Topics: Adult; Aged; Angina Pectoris; Canada; Coronary Angiography; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Nicorandil; Nitroglycerin; No-Reflow Phenomenon; Single-Blind Method; Treatment Outcome; Vasodilator Agents | 2015 |
Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Circulation; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Nicorandil; Prospective Studies; Treatment Outcome | 2009 |
Nicorandil infusion leads to good recovery from ischemia of left ventricular regional work in comparison with nitroglycerin.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Nitroglycerin; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Nicorandil-induced preconditioning as evidenced by troponin T measurements after coronary angioplasty in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Female; Humans; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Nicorandil; Sensitivity and Specificity; Troponin T | 2002 |
Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy.
Topics: Aged; Angina Pectoris; Atherectomy, Coronary; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Recurrence; Vasodilator Agents; Verapamil | 2002 |
Impact of nicorandil in angina: subgroup analyses.
Topics: Angina Pectoris; Confidence Intervals; Coronary Disease; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Proportional Hazards Models; Risk Factors; Treatment Outcome; Vasodilator Agents | 2004 |
The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
Topics: Adaptation, Physiological; Angina Pectoris; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Double-Blind Method; Electrocardiography; Enalapril; Exercise Test; Female; Humans; Ischemic Preconditioning, Myocardial; Losartan; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Potassium Channels; Regression Analysis; Vasodilator Agents | 2005 |
Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina.
Topics: Aged; Angina Pectoris; Angiography; Angioplasty, Balloon, Coronary; Biomarkers; Cardiotonic Agents; Echocardiography; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Stroke Volume; Treatment Outcome | 2005 |
Economic evaluation of the impact of nicorandil in angina (IONA) trial.
Topics: Angina Pectoris; Cardiovascular Diseases; Cerebrovascular Disorders; Cost-Benefit Analysis; Gastrointestinal Diseases; Hospital Costs; Hospitalization; Humans; Nicorandil; Vasodilator Agents | 2006 |
Effect of intravenous nicorandil and preexisting angina pectoris on short- and long-term outcomes in patients with a first ST-segment elevation acute myocardial infarction.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Nicorandil; Time Factors; Treatment Outcome; Vasodilator Agents | 2007 |
Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in China.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; China; Double-Blind Method; Exercise; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Nitroglycerin; Vasodilator Agents | 2007 |
Coronary microvascular response to intracoronary administration of nicorandil.
Topics: Adult; Aged; Angina Pectoris; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Coronary Vessels; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Microcirculation; Middle Aged; Niacinamide; Nicorandil; Papaverine; Vascular Resistance; Vasodilator Agents | 1995 |
A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
Topics: Aged; Angina Pectoris; Coronary Circulation; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1993 |
A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Coronary Circulation; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Vasodilator Agents | 1993 |
A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Niacinamide; Nicorandil; Nitroglycerin; Vasodilator Agents | 1993 |
Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Topics: Angina Pectoris; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Niacinamide; Nicorandil; Sick Sinus Syndrome; Vasodilator Agents | 1995 |
[Effects of nicorandil on coronary collateral circulation depend on the donor arteries].
Topics: Adult; Aged; Angina Pectoris; Collateral Circulation; Coronary Circulation; Exercise Test; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Perfusion; Physical Endurance; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1996 |
[Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Exercise Test; Humans; Isosorbide Dinitrate; Myocardial Ischemia; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1995 |
Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
Topics: Administration, Oral; Aged; Angina Pectoris; Coronary Angiography; Cross-Over Studies; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Conduction System; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Niacinamide; Nicorandil; Reproducibility of Results; Vasodilator Agents | 1997 |
Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diltiazem; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Time Factors; Verapamil | 1999 |
[Nicorandil: acute hemodynamic effects of 2 different oral doses of a potassium channel opener in patients with coronary heart disease].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Calcium Channels; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Nicorandil; Treatment Outcome | 1999 |
Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Electrocardiography; Female; Hemodynamics; Humans; Injections, Intravenous; Ischemic Preconditioning, Myocardial; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Time Factors; Treatment Outcome; Vasodilator Agents | 2000 |
Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management.
Topics: Angina Pectoris; Chest Pain; Cohort Studies; Coronary Disease; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Research Design; Risk Factors; Treatment Outcome; Vasodilator Agents | 2001 |
Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty.
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Middle Aged; Nicorandil; Premedication; Treatment Outcome | 2001 |
Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Electrocardiography; Female; Humans; Ischemic Preconditioning, Myocardial; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Premedication; Vasodilator Agents | 2001 |
Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Chest Pain; Collateral Circulation; Electrocardiography; Female; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Patient Selection; Vasodilator Agents | 2002 |
Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.
Topics: Aged; Angina Pectoris; Double-Blind Method; Endpoint Determination; Female; Humans; Male; Nicorandil; Risk Factors; Survival Analysis; United Kingdom; Vasodilator Agents | 2002 |
Angina, diabetes and SUR.
Topics: Angina Pectoris; Antihypertensive Agents; ATP-Binding Cassette Transporters; Diabetic Angiopathies; Humans; Ion Channel Gating; Nicorandil; Placebos; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors | 2002 |
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
Topics: Angina Pectoris; Animals; Biological Availability; Drug Interactions; Drug Tolerance; Hemodynamics; Humans; Niacinamide; Nicorandil; Nitrates; Potassium Channels; Vasodilator Agents | 1992 |
Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
Topics: Angina Pectoris; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Exercise; Heart Rate; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Propranolol; Vasodilator Agents | 1992 |
Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise; Female; Heart Rate; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Nifedipine; Potassium Channels; Tablets | 1992 |
Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy.
Topics: Administration, Oral; Administration, Sublingual; Angina Pectoris; Drug Administration Schedule; Drug Tolerance; Exercise; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Niacinamide; Nicorandil; Nitroglycerin | 1992 |
[A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
Topics: Aged; Angina Pectoris; Double-Blind Method; Exercise Test; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Placebos; Vasodilator Agents | 1991 |
Comparison of nicorandil and atenolol in stable angina pectoris.
Topics: Angina Pectoris; Atenolol; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Headache; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Randomized Controlled Trials as Topic; Single-Blind Method; Vasodilator Agents | 1990 |
Pharmacology and therapeutic effects of nicorandil.
Topics: Angina Pectoris; Animals; Coronary Vessels; Drug Interactions; Hemodynamics; Humans; Niacinamide; Nicorandil; Vasodilator Agents | 1990 |
Effect of nicorandil on exercise performance in patients with effort angina: a multicenter trial using a treadmill exercise test.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Physical Exertion; Random Allocation; Vasodilator Agents | 1987 |
Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Physical Exertion; Placebos; Random Allocation; Stroke Volume; Vasodilator Agents | 1989 |
A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Physical Exertion; Placebos; Random Allocation; Time Factors; Vasodilator Agents | 1989 |
Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris.
Topics: Administration, Oral; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Physical Exertion; Placebos; Random Allocation; Vasodilator Agents | 1989 |
Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Diltiazem; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Propranolol; Random Allocation; Vasodilator Agents | 1989 |
Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Female; Humans; Male; Middle Aged; Niacinamide; Nicorandil | 1986 |
Effects of nicorandil on exercise tolerance in patients with stable effort angina: a double-blind study.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Nitroglycerin; Physical Endurance; Physical Exertion; Placebos; Time Factors; Vasodilator Agents | 1986 |
66 other study(ies) available for nicorandil and Angor Pectoris
| Article | Year |
|---|---|
New antianginal nitro esters with reduced hypotensive activity. Synthesis and pharmacological evaluation of 3-[(nitrooxy)alkyl]-2H-1,3-benzoxazin-4(3H)-ones.
Topics: Angina Pectoris; Animals; Benzoxazines; Blood Pressure; Hemodynamics; Hypotension; In Vitro Techniques; Ischemia; Male; Niacinamide; Nicorandil; Nitrates; Nitroglycerin; Oxazines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vasodilator Agents | 1995 |
Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study.
Topics: Adult; Angina Pectoris; Coronary Disease; Humans; Nicorandil; Retrospective Studies; Trimetazidine | 2022 |
[Ulcers in vulva and perineum induced by an anti-anginal drug].
Topics: Aged; Angina Pectoris; Female; Humans; Nicorandil; Perineum; Ulcer; Vasodilator Agents; Vulva | 2022 |
Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Female; Fractional Flow Reserve, Myocardial; Humans; Hyperemia; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Time Factors; Vasodilator Agents; Young Adult | 2019 |
A case of vasospastic angina in which the ergonovine provocation test with intracoronary isosorbide dinitrate and nicorandil was effective in the diagnosis of microvascular spasm.
Topics: Angina Pectoris; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Ergonovine; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Oxytocics; Vasodilator Agents | 2014 |
Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Coronary Vasospasm; Female; Humans; Isosorbide; Male; Nicorandil; Nitrates; Nitroglycerin; Prognosis; Prospective Studies; Registries; Retrospective Studies | 2015 |
Risk of skin ulcerations associated with oral nicorandil therapy: a population-based study.
Topics: Administration, Oral; Aged; Angina Pectoris; Female; Humans; Male; Nicorandil; Prospective Studies; Risk Factors; Skin Ulcer; Vasodilator Agents | 2015 |
Development, optimization, and characterization of polymeric electrospun nanofiber: a new attempt in sublingual delivery of nicorandil for the management of angina pectoris.
Topics: Administration, Sublingual; Angina Pectoris; Animals; Drug Carriers; Goats; Humans; Nanofibers; Nicorandil | 2016 |
[Comparative Assessment of Effects of Isosorbide Dinitrate, Isosorbide-5-Mononitrate and Nicorandil on the Frequency of Angina Attacks and Vasoregulating Endothelial Function in Patients With Ischemic Heart Disease].
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Female; Humans; Incidence; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Risk Assessment; Russia; Vasodilation | 2015 |
Effect of Long-Term Administration of Nicorandil on Endothelial Function of the Radial Artery in Patients With Angina Undergoing Transradial Percutaneous Coronary Intervention.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angiography; Endothelial Cells; Female; Heart; Humans; Male; Middle Aged; Nicorandil; Nitroglycerin; Percutaneous Coronary Intervention; Radial Artery; Time | 2017 |
Nicorandil: serious gastrointestinal ulceration.
Topics: Angina Pectoris; Drug Approval; Fissure in Ano; France; Gastrointestinal Tract; Humans; Nicorandil; Peptic Ulcer | 2008 |
[Severe arrhythmia after gastrectomy in patients with history of coronary bypass graft surgery using right gastroepiploic artery].
Topics: Aged; Anesthesia; Angina Pectoris; Arrhythmias, Cardiac; Coronary Artery Bypass; Defibrillators, Implantable; Dobutamine; Gastrectomy; Gastroepiploic Artery; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Postoperative Complications; Severity of Illness Index; Stomach Neoplasms; Treatment Outcome | 2008 |
Vulvovaginal ulceration during prolonged treatment with nicorandil.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Humans; Long-Term Care; Nicorandil; Pain; Ulcer; Vasodilator Agents; Vulvar Diseases; Vulvovaginitis | 2009 |
Vulval ulceration induced by the potassium-channel activator Nicorandil: a case series of five patients.
Topics: Aged; Angina Pectoris; Female; Humans; Middle Aged; Nicorandil; Pain; Pruritus Vulvae; Ulcer; Vasodilator Agents; Vulvar Diseases; Vulvitis | 2009 |
Nicorandil-induced penile ulcerations: a case series.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Humans; Male; Nicorandil; Penile Diseases; Ulcer; Vasodilator Agents | 2011 |
Diverticular fistulation is associated with nicorandil usage.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Case-Control Studies; Diverticulum, Colon; Female; Humans; Intestinal Fistula; Male; Middle Aged; Nicorandil; Rectovaginal Fistula; Vasodilator Agents | 2010 |
Nicorandil: a curable cause of anal ulceration to be known...
Topics: Aged; Angina Pectoris; Fissure in Ano; Humans; Male; Nicorandil; Prognosis; Risk Assessment; Severity of Illness Index; Time Factors; Vasodilator Agents | 2010 |
Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angina Pectoris; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Cardiovascular Agents; Cells, Cultured; Chi-Square Distribution; Coronary Artery Disease; Cytokines; Disease Models, Animal; Drug Administration Schedule; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endothelial Cells; Fibrosis; Humans; Inflammation Mediators; Japan; Lipids; Logistic Models; Macrophages; Male; Mice; Mice, Knockout; Middle Aged; Molecular Chaperones; Necrosis; Nicorandil; Odds Ratio; Retrospective Studies; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2011 |
Nicorandil-induced leg ulceration without mucosal involvement.
Topics: Aged; Angina Pectoris; Arthroplasty, Replacement, Knee; Female; Humans; Leg Ulcer; Nicorandil; Postoperative Complications; Vasodilator Agents; Wound Healing | 2011 |
Nicorandil induced penile ulceration.
Topics: Aged, 80 and over; Angina Pectoris; Humans; Male; Nicorandil; Penis; Skin Ulcer; Vasodilator Agents | 2010 |
[Nicorandil and ulceration: a physiopathological hypothesis].
Topics: Angina Pectoris; Drug Eruptions; Humans; NAD; NADP; Niacin; Niacinamide; Nicorandil; Skin; Skin Ulcer; Vasodilator Agents | 2012 |
Nicorandil associated anal ulcers: an estimate of incidence.
Topics: Aged; Aged, 80 and over; Angina Pectoris; England; Female; Fissure in Ano; Humans; Incidence; Male; Middle Aged; Nicorandil; Vasodilator Agents | 2012 |
Nicorandil: do the dermatological and gastrointestinal risks outweigh the benefits?
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Gastrointestinal Diseases; Humans; Intestinal Fistula; Intestinal Perforation; Male; Middle Aged; Nicorandil; Risk Assessment; Skin Ulcer; Vasodilator Agents | 2012 |
Leg ulcers associated with nicorandil are possibly underdiagnosed.
Topics: Angina Pectoris; Female; Humans; Leg Ulcer; Nicorandil; Vasodilator Agents | 2013 |
Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels.
Topics: Adenosine Triphosphate; Angina Pectoris; Creatine Kinase; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Mitochondria, Heart; Nicorandil; Potassium Channels; Vasodilator Agents | 2002 |
Nicorandil: a drug for many purposes: too good to be true?
Topics: Angina Pectoris; Cardiomyopathy, Hypertrophic; Humans; Myocardial Ischemia; Nicorandil; Vasodilator Agents | 2003 |
Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Anti-Arrhythmia Agents; Calcium Channel Blockers; Coronary Artery Disease; Female; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2004 |
Chronic anal ulceration due to nicorandil.
Topics: Angina Pectoris; Chronic Disease; Fissure in Ano; Humans; Male; Middle Aged; Nicorandil; Vasodilator Agents | 2004 |
Nicorandil associated anal ulceration.
Topics: Aged; Angina Pectoris; Colonoscopy; Female; Fissure in Ano; Follow-Up Studies; Humans; Male; Middle Aged; Nicorandil; Risk Assessment; Sampling Studies; Severity of Illness Index; Vasodilator Agents | 2004 |
Insulin resistance relates to acetylcholine-induced microvascular vasoconstriction in a patient with vasospastic angina: potential implication of causalities between hyperinsulinemia and coronary microcirculation failure.
Topics: Acetylcholine; Aged; Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vasospasm; Electrocardiography; Humans; Hyperinsulinism; Infusions, Intra-Arterial; Insulin Resistance; Isosorbide Dinitrate; Male; Microcirculation; Nicorandil; Treatment Outcome; Vasoconstriction; Vasodilator Agents | 2005 |
Nicorandil and idiopathic anal ulceration.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Fissure in Ano; Humans; Male; Middle Aged; Nicorandil; Vasodilator Agents | 2005 |
Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment.
Topics: Adrenergic beta-Agonists; Angina Pectoris; Blood Pressure; Coronary Vasospasm; Electrocardiography; Ethanolamines; Female; Heart Rate; Humans; Middle Aged; Nicorandil; Nitrates; Recurrence; Treatment Failure; Vasodilator Agents | 2006 |
Nicorandil: the drug that keeps on giving.
Topics: Angina Pectoris; Animals; Cardiotonic Agents; Humans; Hypertension; Nicorandil; Potassium Channels; Vasodilator Agents | 2005 |
Determinants of coronary events in patients with stable angina: results from the impact of nicorandil in angina study.
Topics: Aged; Angina Pectoris; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Nicorandil; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vasodilator Agents | 2005 |
Nicorandil inhibits serum starvation-induced apoptosis in vascular endothelial cells.
Topics: Angina Pectoris; Apoptosis; Benzimidazoles; Cells, Cultured; Culture Media, Serum-Free; Decanoic Acids; Endothelial Cells; Humans; Hydroxy Acids; Ion Channels; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nicorandil; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-bcl-2 | 2005 |
[Angina pectoris presenting with unusual form of coronary spasm: a case report].
Topics: Angina Pectoris; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Humans; Male; Middle Aged; Nicorandil; Nitroglycerin; Vasodilator Agents | 2006 |
Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Topics: Administration, Oral; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Female; Humans; Japan; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Nicorandil; Prognosis; Renal Dialysis; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Vasodilator Agents | 2007 |
Perianal ulceration and other cutaneous ulcerations complicating nicorandil therapy.
Topics: Aged; Angina Pectoris; Fatal Outcome; Female; Fissure in Ano; Humans; Nicorandil; Vasodilator Agents | 2007 |
Perianal fistula, colorectal surgery and nicorandil.
Topics: Aged; Angina Pectoris; Anti-Arrhythmia Agents; Humans; Male; Nicorandil; Rectal Fistula; Time Factors; Treatment Outcome | 2008 |
Anal ulceration induced by nicorandil.
Topics: Aged; Angina Pectoris; Fissure in Ano; Humans; Male; Nicorandil; Ulcer; Vasodilator Agents | 2007 |
Nicorandil-induced severe perianal ulceration.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Female; Fissure in Ano; Follow-Up Studies; Humans; Male; Middle Aged; Nicorandil; Prognosis; Retrospective Studies; Severity of Illness Index; Time Factors; Vasodilator Agents | 2007 |
[Studies on the relation between collateral development and the effects of antianginal drugs--effects of nitroglycerin and 2-nicotinamidethyl nitrate on collateral circulation (author's transl)].
Topics: Angina Pectoris; Animals; Collateral Circulation; Coronary Circulation; Dogs; Niacinamide; Nicorandil; Nitrates; Nitroglycerin | 1981 |
Effects of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) on methacholine-induced ECG changes in intact anesthetized rats.
Topics: Acetylcholine; Anesthesia; Angina Pectoris; Animals; Blood Pressure; Brain; Electrocardiography; Heart; Male; Methacholine Compounds; Niacinamide; Nicorandil; Nitrates; Rats; Rats, Inbred Strains; Vasodilator Agents | 1981 |
Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris.
Topics: Administration, Oral; Aged; Angina Pectoris; Blood Pressure; Energy Metabolism; Exercise; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Placebo Effect; Purines; Time Factors; Vasodilator Agents | 1995 |
Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP-inhibitable cyclic AMP phosphodiesterase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Angina Pectoris; Animals; Aorta; Cyclic AMP; Cyclic GMP; Drug Synergism; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Rats; Rats, Wistar; Vasodilator Agents | 1995 |
[Therapeutic application of myocardial cytoprotection].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 1994 |
Evaluation of the efficacy of nicorandil in patients with ischemic heart disease by exercise Tl-201 myocardial SPECT.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Antihypertensive Agents; Coronary Angiography; Coronary Artery Bypass; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Niacinamide; Nicorandil; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1994 |
Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
Topics: Angina Pectoris; Animals; Disease Models, Animal; Electrocardiography; Injections, Intravenous; Isoproterenol; Male; Methacholine Chloride; Niacinamide; Nicorandil; Nifedipine; Pyridines; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Circulation; Drug Monitoring; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1993 |
Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Circulation; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Niacinamide; Nicorandil; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1993 |
Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Circulation; Exercise Test; Female; Heart; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Radionuclide Imaging; Thallium Radioisotopes; Vasodilator Agents | 1995 |
Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle.
Topics: Adenosine Triphosphate; Adult; Aged; Angina Pectoris; Benzopyrans; Cromakalim; Female; Guanidines; Heart Atria; Humans; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Contraction; Niacinamide; Nicorandil; Potassium Channels; Vasodilator Agents | 1997 |
Effect of JTV-506, a novel vasodilator, on experimental angina model in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Arginine Vasopressin; Blood Pressure; Chromans; Cromakalim; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Injections, Intravenous; Male; Methacholine Chloride; Molecular Structure; Niacinamide; Nicorandil; Nifedipine; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
Association of major aphthous ulcers and nicorandil.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Anti-Arrhythmia Agents; Female; Humans; Male; Middle Aged; Nicorandil; Stomatitis, Aphthous | 1998 |
[Therapy recommendations for adverse effects of Viagra and nitrates (NO-donors)].
Topics: Angina Pectoris; Blood Pressure; Contraindications; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Molsidomine; Nicorandil; Nitrates; Nitric Oxide Donors; Piperazines; Purines; Sildenafil Citrate; Sulfones | 1998 |
Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs.
Topics: Angina Pectoris; Animals; Atenolol; Blood Pressure; Diltiazem; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Male; Nicorandil; Propranolol; Vasodilator Agents | 1998 |
Estimation of coronary flow reserve by intracoronary administration of nicorandil: comparison with intracoronary administration of papaverine.
Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Vessels; Electrocardiography; Female; Humans; Male; Myocardial Infarction; Nicorandil; Papaverine; Vasodilator Agents | 1998 |
Nicorandil can induce severe oral ulceration.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Angina Pectoris; Anti-Arrhythmia Agents; Europe; Female; Humans; Male; Middle Aged; Mouth Mucosa; Nicorandil; Oral Ulcer; Potassium Channels; Time Factors; Tongue Diseases; Vasodilator Agents | 2001 |
Lack of antagonism between nicorandil and sulfonylurea in stable angina pectoris.
Topics: Aged; Angina Pectoris; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Electrocardiography; Exercise Test; Female; Glycated Hemoglobin; Hemodynamics; Humans; Hypoglycemic Agents; Male; Middle Aged; Nicorandil; Sulfonylurea Compounds; Vasodilator Agents | 2001 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Isoproterenol; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nicorandil; Nifedipine; Propranolol; Pyrroles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium-Hydrogen Exchangers; Vasodilator Agents; Vasopressins | 2002 |
Beneficial effects of nicorandil on cardiovascular hemodynamics and left ventricular function.
Topics: Angina Pectoris; Cardiac Catheterization; Cardiac Pacing, Artificial; Coronary Disease; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Vasodilator Agents | 1987 |
A symposium: A new treatment for angina pectoris and heart failure. October 17, 1987, San Francisco. Proceedings.
Topics: Angina Pectoris; Animals; Heart Failure; Humans; Niacinamide; Nicorandil; Vasodilator Agents | 1989 |
Chronic effects of nicorandil on exercise tolerance in patients with stable effort angina pectoris.
Topics: Adult; Angina Pectoris; Electrocardiography; Exercise; Female; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Vasodilator Agents | 1989 |
[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Vasospasm; Electrocardiography; Hypoxia; Isosorbide Dinitrate; Lypressin; Male; Molsidomine; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Rats; Rats, Inbred Strains; Verapamil | 1986 |
Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Diltiazem; Drug Resistance; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Niacinamide; Nicorandil; Nifedipine; Physical Exertion; Prospective Studies; Rest; Vasodilator Agents | 1987 |
Protective effects of the antianginal agent nicorandil on arachidonate-induced sudden death in rats: comparison with several antianginal agents and cyclooxygenase inhibitors.
Topics: Angina Pectoris; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cyclooxygenase Inhibitors; Death, Sudden; Diltiazem; Indomethacin; Male; Mice; Niacinamide; Nicorandil; Nitroglycerin; Rats; Rats, Inbred Strains; Vasodilator Agents | 1985 |